Preliminary Market Engagement Notice: Targeted Tender - 146622879

Procurement Summary

Country: United Kingdom

Summary: Preliminary Market Engagement Notice: Targeted Prostate Cancer Screening Programme - Psa Testing, Mri Reporting and Brca Digital Decision Resource

Deadline: 26 Aug 2026

Posting Date: 06 Aug 2026

Other Information

Notice Type: Tender

TOT Ref.No.: 146622879

Document Ref. No.: C463159

Competition: ICB

Financier: Self Financed

Purchaser Ownership: Public

Tender Value: Refer Document

CPV Classification

85100000 - Health services
85145000 - Services provided by medical laboratories
85148000 - Medical analysis services
85150000 - Medical imaging services
72413000 - World wide web (www) site design services
72212220 - Internet and intranet software development services
72000000 - IT services: consulting, software development, Internet and support

Purchaser's Detail

Name: Login to see tender_details

Address: Login to see tender_details

Email: Login to see tender_detailsLogin to see details

Tender Details

Preliminary Market Engagement / Early Market Engagement NHS England is undertaking preliminary market engagement to inform three separate but connected requirements within the Targeted Prostate Cancer Screening Programme. The proposed workstreams are: 1. PSA laboratory processing and pathway support; 2. prostate MRI reporting; 3. BRCA digital decision resource / website development and evaluation. The programme is being developed to support targeted prostate cancer screening for men at increased risk, including men with a known pathogenic or likely pathogenic BRCA2 variant. The purpose of this engagement is to understand market capability, potential delivery models, mobilisation requirements, key risks, pricing assumptions, digital and information governance considerations, pathway interfaces and route-to-market options. The workstreams involve different capabilities and provider markets. NHS England may procure the requirements separately, and different procurement routes may apply to different workstreams. NHS England is currently assessing the most appropriate route to market for each workstream. Subject to completion of the relevant approvals and assessments, Workstreams 1 and 2 are anticipated to be procured under the Provider Selection Regime where confirmed as being within scope of that regime. Workstream 3 is anticipated to be procured in accordance with the Procurement Act 2023. This engagement is not a call for competition, does not commence a procurement process, a...

Documents

 Tender Notice